TFS HealthScience expands collaboration with Oncomatryx for phase Ib trial of OMTX705 for pancreatic cancer

Join Pharma | Login

	Editorial


	THE FORCED SWIM TEST
	Tuesday, May 6, 2025
	The animal rights organization, People for the Ethical Treatment of Animals (PETA) has recently sent a letter to the Pharmacy Council of India (PCI) for discontinuing the Forced Swim Test (FST) in thousands of
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	TFS HealthScience expands collaboration with Oncomatryx for phase Ib trial of OMTX705 for pancreatic cancer
17:00 [IST]	Castle Biosciences inks agreement to buy Previse
16:20 [IST]	Novopor acquires US-based Pressure Chemical Company to strengthen global specialty chemicals platform
16:10 [IST]	Poly Medicure net profit grows 34 per cent in Q4FY25
16:00 [IST]	Innocan Pharma’s proprietary topical pain-relief technology receives Mexican patent
15:45 [IST]	Alembic Pharma reports 12% decline in net profit during Q4FY25

more news >>

TOP NEWS


08:00 [IST]	DTAB ratifies extension of timeline for revised Schedule M implementation for MSMEs
08:00 [IST]	Number of NSQ drugs has declined considerably in Gujarat during the last 10 years: Dr H G Koshia
08:00 [IST]	Indian pharma upholds Union govt’s blanket ban on trade with Pakistan in response to national security concerns
08:00 [IST]	Specialization in B Pharm will increase job opportunities for pharmacy graduates: Dr Deependra Singh
08:00 [IST]	Indian healthcare sector notes rise of AI in operating theatres transforms surgical interventions
08:00 [IST]	DTAB recommends all antimicrobials to be considered as new drug under NDCT Rules

more news >>

YESTERDAY'S NEWS


17:50 [IST]	Amrita Vishwa Vidyapeetham wins C-CAMP GAMRIF AMR Challenge 2024–25
17:40 [IST]	Senores Pharmaceuticals appoints Gautam Shah as president of US operations
17:30 [IST]	TPG will acquire 35% stake in SCHOTT Poonawalla from Serum Institute of India
16:45 [IST]	Breach Candy Hospital launches advanced modular operation theatres in collaboration with Dräger India
12:50 [IST]	Yashoda Medicity introduces Elekta Unity MR Linac with integrated CMM
12:40 [IST]	Fujifilm India set up ‘Fujifilm Skill Club’ transforming healthcare with knowledge, collaboration, and resources

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Poly Medicure net profit grows 34 per cent in Q4FY25 Alembic Pharma reports 12% decline in net profit during Q4FY25 OneSource reports Rs. 426 crore revenues with 22% growth in Q4 & 30% rise at Rs. 1,444.9 crore in FY25 Syngene’s revenue from operations crossed Rs. 1,000 crore mark in Q4, PAT dips by 3%, full year earnings up 4% to Rs. 3,642 crore Methotrexate 2.5 Mg Tab/cap

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers